medicaid semaglutide US states drop coverage of GLP-1 weight-loss drugs as demand rises | US healthcare The Trump administration is preparing

10.3390/ijms141121513 Int

There are three distinct categories and each carries different implications for quality, legality and safety

It is encouraging to see that semaglutide an important medication that has been shown to be beneficial in patients with diabetes, as well as patients with obesity has the capability of slowing [the] progression of kidney disease as well, commented Chen

These include improvements in cardiovascular outcomes, making it particularly relevant for patients with type 2 diabetes who are at higher risk of heart disease. Such benefits have positioned semaglutide as a comprehensive metabolic therapy rather than a single-purpose drug

I want to see if I can do without it, she recalled

Go slower